Vidofludimus hemicalcium, CAS [[1354012-90-0]]

Produktübersicht

• Artikelname: Vidofludimus hemicalcium, CAS [[1354012-90-0]]
• Artikelnummer: TGM-T70899
• Hersteller Artikelnummer: T70899
• Alternativnummer: TGM-T70899-25MG,TGM-T70899-50MG,TGM-T70899-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: 4sc-101 hemicalcium , SC12267 hemicalcium , 4sc-101 hemicalcium , SC12267 hemicalcium

Produktbeschreibung

Vidofludimus hemicalcium (4sc-101, SC12267) is an orally active compound that acts as a dihydroorotate dehydrogenase (DHODH) inhibitor and serves as a novel modulator of the farnesoid X receptor (FXR). This immunomodulatory agent is utilized in the research of autoimmune disorders, including inflammatory bowel disease (IBD), and is explored for its potential in fatty liver disease research through FXR targeting.

Produkteigenschaften

• Molekulargewicht: 375.4
• CAS Nummer: [1354012-90-0]
• Formel: C20H18FNO4.1/2Ca
• Target-Kategorie: Others|||Interleukin|||FXR|||Dehydrogenase

Bilder

T70899